Abstract
Purpose: Studies report that plasma NT-proBNP and BNP have prognostic value for mortality in the general population even in the absence of heart failure (HF). It is unclear if NT-proBNP and BNP retain prognostic value in individuals who are free of traditional cardiovascular risk factors (CV RFs) or structural cardiac abnormalities (SCA). Methods: We identified a community-based cohort of 2,006 subjects in Olmsted Co, Minnesota. We excluded those with HF. The remaining 1,991 subjects underwent echocardiography, NT-proBNP (Roche) and BNP (Biosite and Shionogi) measurement, and identification of age/gender specific 80th percentile NT-proBNP and BNP levels.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
